April 27, 2024
Bio
Samsung BioLogics snaps 3-day winning streak
[THE INVESTOR] Samsung BioLogics shares have rallied over 30 percent from the offering price, competing with heavyweights in the biotechnology sector.
 |
Shares of Samsung Group’s contract biotech drug manufacturing arm traded at 177,000 won (US$151.8) in early morning session on Nov. 15, up 30.14 percent from the offering price of 136,000 won.
The company now has a market capitalization of 11.74 trillion buoyed by its three-day winning streak since its market debut on Nov. 10, making it the 23rd largest firm on the benchmark KOSPI.
This takes Samsung BioLogics one step closer to biotechnology heavyweights like Celltrion, the largest firm listed on the secondary bourse KOSDAQ with market cap of 12.16 trillion won.
By Park Han-na (hnpark@heraldcorp.com)
